Cardiopulmonary Exercise Testing Helps Evaluate Survival Chances After Liver Transplantation

Preoperative cardiopulmonary exercise testing (CPET) helps predict survival following liver transplantation, a recent study has revealed.

Study results available in the February issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, shows that the CPET measurement—the anaerobic threshold or fitness level—significantly predicts mortality in patients post-transplantation.

Liver Transplant from Mother More Tolerable for Children With Rare Disease
Children with biliary atresia, a rare, life-threatening disease that is the most common cause of neonatal liver failure, better tolerate liver transplants from their mothers than from their fathers

CPET is a non-invasive measure of cardiorespiratory fitness and has been previously used as a predictor of morbidity and mortality following other types of major surgeries. "Liver transplantation carries a significant mortality risk in the early days following surgery," explains Dr. James Prentis from Freeman Hospital in Newcastle upon Tyne in the U.K. "An accurate preoperative assessment like CPET could help minimize patient mortality and optimize limited donor organs."

For the current study, researchers included CPET as part of the preoperative assessment in 182 patients undergoing liver transplantation at Freeman Hospital over a 3-year period. Of those in the study, 91% (165) successfully completed the CPET which the team defined as the ability to determine the anaerobic threshold. Following transplantation patients received follow-up to determine 90-day mortality, critical care and length of hospital stay.

Findings report that 60 patients (33%) received a liver transplant and of those 6 (10%) died following transplantation. The mean anaerobic threshold was significantly higher in survivors compared to non-survivors, with multivariate analysis showing cardiopulmonary reserve to be a significant predictor of mortality. Dr. Prentis concludes, "CPET is a non-invasive, sensitive and specific predictor of survival following liver transplantation. However, further evaluation of its predictive value in larger cohorts is necessary."

200th Liver Transplant Surgery on Pakistani Patient Performed at Delhi Hospital
A New Delhi hospital can now boast of a major achievement in its contribution to India-Pakistan relations

In a related editorial also published in Liver Transplantation, Dr. James Findlay from the Mayo Clinic in Rochester, Minnesota writes, "While CPET is widely available there are similar preoperative assessments such as the six-minute walking test that could also be used. Liver transplantation specialists have a duty to provide candidates with an accurate risk-benefit assessment and ensure that scarce donor organs are used effectively. The findings of Prentis and colleagues are striking enough to merit further evaluation." Dr. Findlay suggests large, multi-center investigations of CPET that include additional mortality indicators are necessary to develop an outcome model that could be widely used in evaluating candidates for liver transplantation.

Rebound of Hepatitis C Virus in Liver Transplant Patients Prevented by Experimental Drug
A human monoclonal antibody that was given to patients with chronic hepatitis C virus (HCV) infection undergoing liver transplantation significantly suppressed the virus

Source-Eurekalert

Lung Cancer Risk High Among Heart and Liver Transplant Recipients
Lung cancer risk is high among heart and liver transplant recipients, it was reported at the 2nd European Lung Cancer Conference.